SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies

SARS-CoV-2 Beta variant of concern (VOC) resists neutralization by major classes of antibodies from COVID-19 patients and vaccinated individuals. Here, serum of Beta-infected patients revealed reduced cross-neutralization of wildtype virus. From these patients, we isolated Beta-specific and cross-re...

Descripción completa

Detalles Bibliográficos
Autores principales: Reincke, S. Momsen, Yuan, Meng, Kornau, Hans-Christian, Corman, Victor M., van Hoof, Scott, Sánchez-Sendin, Elisa, Ramberger, Melanie, Yu, Wenli, Hua, Yuanzi, Tien, Henry, Schmidt, Marie Luisa, Schwarz, Tatjana, Jeworowski, Lara Maria, Brandl, Sarah E., Rasmussen, Helle Foverskov, Homeyer, Marie A., Stöffler, Laura, Barner, Martin, Kunkel, Désirée, Huo, Shufan, Horler, Johannes, von Wardenburg, Niels, Kroidl, Inge, Eser, Tabea M., Wieser, Andreas, Geldmacher, Christof, Hoelscher, Michael, Gänzer, Hannes, Weiss, Günter, Schmitz, Dietmar, Drosten, Christian, Prüss, Harald, Wilson, Ian A., Kreye, Jakob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2022
Materias:
Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939768/
https://www.ncbi.nlm.nih.gov/pubmed/35076281
http://dx.doi.org/10.1126/science.abm5835

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939768/
https://www.ncbi.nlm.nih.gov/pubmed/35076281
http://dx.doi.org/10.1126/science.abm5835

Ejemplares similares